The man participated in a trial using stem cells that were injected during surgery after his right shoulder sidelined him from his hobbies, the report said. Follow-up MRIs looked at the recovery.
Three days after surgery, the man didn’t need pain medicine, and he felt recovered after a few weeks, the report said. When his other shoulder gave out, he opted for stem cells again.
“Even though we repair the tendon [during surgery], we stitch it back into place, about 20 percent of the time it may not heal,” Nikhil Verma, MD, director of sports medicine at Midwest Orthopedics at Rush, told ABC12. “In the group that got the stem cells, we could see a marked improvement in the appearance of the tendon compared to the group that did not get the stem cells.”
Read the full report and watch the video here.
More articles on devices:
Robotics in spine surgery: 17 notes for surgeons, ASCs & administrators
Zimmer Biomet net sales increase 2%, knee sales dip .5% in Q3
10 most influential orthopedic specialists on Twitter in Q3, according to GlobalData
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
